The Eighth Joint National Committee (JNC 8) guidelines on hypertension have generated great interest among physicians. These guidelines differ from those published in 2003 (the JNC 7)—in the document format, blood-pressure cut-off values, and recommendations for antihypertensive drug use. The JNC 8 have some limitations that could affect clinical practice.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
James, P. A. et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA http://dx.doi.org/10.1001/jama.2013.284427.
Chobanian, A. V. et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289, 2560–2572 (2003).
Egan, B. M., Zhao, Y. & Axon, R. N. US trends in prevalence, awareness, treatment, and control of hypertension, 1988–2008. JAMA 303, 2043–2050 (2010).
Mancia, G. et al. 2007 guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 25, 1105–1187 (2007).
American Diabetes Association. Hypertension management in adults with diabetes. Diabetes Care 27 (Suppl. 1), S65–S67 (2004).
Zanchetti, A., Grassi, G. & Mancia, G. When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal. J. Hypertens. 27, 923–934 (2009).
Mancia, G. & Grassi, G. Aggressive blood pressure lowering is dangerous. The J-curve: pro side of the argument. Hypertension 63, 29–36 (2014).
The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288, 2981–2997 (2002).
Mancia, G. & Grassi, G. Individualization of antihypertensive drug treatment. Diabetes Care 36 (Suppl. 2), S301–S306 (2013).
Mancia, G. et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J. Hypertens. 31, 1281–1357 (2013).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Mancia, G. Strengths and limitations of the JNC 8 hypertension guidelines. Nat Rev Cardiol 11, 189–190 (2014). https://doi.org/10.1038/nrcardio.2014.12
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2014.12
